WHO ICTRP trial
PROTREAT-TRIAL PROPHYLACTIC ANTIEMETIC TREATMENT OF OPIOID-INDUCED NAUSEA AND…
DRKS00024954 · German Clinical Trials Register · Recruiting
Key facts
| Trial ID | DRKS00024954 |
|---|---|
| Public title | PROTREAT-TRIAL PROPHYLACTIC ANTIEMETIC TREATMENT OF OPIOID-INDUCED NAUSEA AND VOMITING (OINV) IN PALLIATIVE CARE: A RANDOMIZED CONTROLLED PHASE II FEASIBILITY TRIAL |
| Scientific title | PROTREAT-TRIAL PROPHYLACTIC ANTIEMETIC TREATMENT OF OPIOID-INDUCED NAUSEA AND VOMITING (OINV) IN PALLIATIVE CARE: A RANDOMIZED CONTROLLED PHASE II FEASIBILITY TRIAL - ProTreat |
| Primary sponsor | Universitätsklinikum Freiburg Klinik für Palliativmedizin |
| Registry | German Clinical Trials Register |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 2 |
| Countries | Germany |
| Conditions | Opioid induced Nausea and Vomiting (OINV) |
| Interventions | Group 1: Palonosetron (500µg): p.o. single dose 1-2 hours before the start of opioid-theraphy Group 2: Placebo: p.o. single dose 1-2 hours before the start of opioid-theraphy |
| Registration date | Nov 3, 2022 |
| Target size | 30 |
| Secondary IDs | 2021-001543-27 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: